Suppr超能文献

阿尔茨海默病与2型糖尿病:胆碱酯酶之间的联系?

Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?

作者信息

Sridhar Gumpeny Ramachandra, Thota Hanuman, Allam Appa Rao, Suresh Babu Changalasetty, Siva Prasad Akula, Divakar Ch

机构信息

Endocrine and Diabetes Centre, 15-12-16 Krishnanagar, Visakhapatnam 530 002, India.

出版信息

Lipids Health Dis. 2006 Nov 11;5:28. doi: 10.1186/1476-511X-5-28.

Abstract

Alzheimer's disease and type 2 diabetes mellitus tend to occur together. We sought to identify protein(s) common to both conditions that could suggest a possible unifying pathogenic role. Using human neuronal butyrylcholinesterase (AAH08396.1) as the reference protein we used BLAST Tool for protein to protein comparison in humans. We found three groups of sequences among a series of 12, with an E-value between 0-12, common to both Alzheimer's disease and diabetes: butyrylcholinesterase precursor K allele (NP_000046.1), acetylcholinesterase isoform E4-E6 precursor (NP_000656.1), and apoptosis-related acetylcholinesterase (1B41|A). Butyrylcholinesterase and acetylcholinesterase related proteins were found common to both Alzheimer's disease and diabetes; they may play an etiological role via influencing insulin resistance and lipid metabolism.

摘要

阿尔茨海默病和2型糖尿病往往同时发生。我们试图找出这两种病症共有的蛋白质,这些蛋白质可能提示一种潜在的统一致病作用。以人类神经元丁酰胆碱酯酶(AAH08396.1)作为参考蛋白,我们使用BLAST工具在人类中进行蛋白质与蛋白质的比较。在一系列12个序列中,我们发现了三组序列,其E值在0至12之间,阿尔茨海默病和糖尿病均有:丁酰胆碱酯酶前体K等位基因(NP_000046.1)、乙酰胆碱酯酶同工型E4 - E6前体(NP_000656.1)以及凋亡相关乙酰胆碱酯酶(1B41|A)。发现丁酰胆碱酯酶和乙酰胆碱酯酶相关蛋白在阿尔茨海默病和糖尿病中均存在;它们可能通过影响胰岛素抵抗和脂质代谢发挥病因学作用。

相似文献

1
Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Lipids Health Dis. 2006 Nov 11;5:28. doi: 10.1186/1476-511X-5-28.
4
Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Brain Res. 2005 Oct 26;1060(1-2):144-52. doi: 10.1016/j.brainres.2005.08.039. Epub 2005 Oct 5.
5
Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment.
Expert Rev Neurother. 2005 Jan;5(1):101-6. doi: 10.1586/14737175.5.1.101.
6
8
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
J Alzheimers Dis. 2009;16(4):809-21. doi: 10.3233/JAD-2009-0976.
9
Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Neurosci Lett. 2007 Oct 29;427(1):34-8. doi: 10.1016/j.neulet.2007.08.059. Epub 2007 Sep 4.

引用本文的文献

1
Incretin Therapy and Insulin Signaling: Therapeutic Targets for Diabetes And Associated Dementia.
Curr Diabetes Rev. 2024;21(4):57-63. doi: 10.2174/0115733998279875240216093902.
2
Cardio- and Neurometabolic Adipobiology: Consequences and Implications for Therapy.
Int J Mol Sci. 2021 Apr 16;22(8):4137. doi: 10.3390/ijms22084137.
3
The diabetic brain and cognition.
J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. doi: 10.1007/s00702-017-1763-2. Epub 2017 Aug 1.
4
DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review.
Am J Alzheimers Dis Other Demen. 2017 Nov;32(7):444-451. doi: 10.1177/1533317517722005. Epub 2017 Jul 27.
6
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease.
EXCLI J. 2015 May 19;14:684-96. doi: 10.17179/excli2015-252. eCollection 2015.
7
Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug.
PLoS One. 2015 Aug 11;10(8):e0134648. doi: 10.1371/journal.pone.0134648. eCollection 2015.
8
Emerging links between type 2 diabetes and Alzheimer's disease.
World J Diabetes. 2015 Jun 10;6(5):744-51. doi: 10.4239/wjd.v6.i5.744.
9
Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
CNS Neurol Disord Drug Targets. 2014;13(8):1432-9. doi: 10.2174/1871527313666141023141545.

本文引用的文献

1
2
From in vivo to in silico biology and back.
Nature. 2006 Oct 5;443(7111):527-33. doi: 10.1038/nature05127.
3
Control of peripheral nerve myelination by the beta-secretase BACE1.
Science. 2006 Oct 27;314(5799):664-6. doi: 10.1126/science.1132341. Epub 2006 Sep 21.
4
Links between Alzheimer's disease and diabetes.
Drugs Today (Barc). 2006 Jul;42(7):481-9. doi: 10.1358/dot.2006.42.7.973588.
5
A computational study of the deacylation mechanism of human butyrylcholinesterase.
Biochemistry. 2006 Jun 20;45(24):7529-43. doi: 10.1021/bi052176p.
6
Butyrylcholinesterase attenuates amyloid fibril formation in vitro.
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8628-33. doi: 10.1073/pnas.0602922103. Epub 2006 May 26.
9
Reactive oxygen species have a causal role in multiple forms of insulin resistance.
Nature. 2006 Apr 13;440(7086):944-8. doi: 10.1038/nature04634.
10
Cholinesterase inhibitors for Alzheimer's disease.
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验